New Results
Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells
Emi Sano, Ayaka Sakamoto, Natsumi Mimura, Ai Hirabayashi, Yukiko Muramoto, Takeshi Noda, Takuya Yamamoto, Kazuo Takayama
doi: https://doi.org/10.1101/2021.02.22.432218
Emi Sano
1Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan
Ayaka Sakamoto
1Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan
Natsumi Mimura
1Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan
Ai Hirabayashi
2Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan
3CREST, Japan Science and Technology Agency (JST), Kawaguchi 332-0012, Japan
Yukiko Muramoto
2Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan
3CREST, Japan Science and Technology Agency (JST), Kawaguchi 332-0012, Japan
Takeshi Noda
2Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan
3CREST, Japan Science and Technology Agency (JST), Kawaguchi 332-0012, Japan
Takuya Yamamoto
1Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan
4Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto 606-8501 Japan
5Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto 606-8507, Japan
6AMED-CREST, Japan Agency for Medical Research and Development (AMED), Tokyo 100-0004, Japan
Kazuo Takayama
1Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan

Article usage
Posted February 22, 2021.
Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells
Emi Sano, Ayaka Sakamoto, Natsumi Mimura, Ai Hirabayashi, Yukiko Muramoto, Takeshi Noda, Takuya Yamamoto, Kazuo Takayama
bioRxiv 2021.02.22.432218; doi: https://doi.org/10.1101/2021.02.22.432218
Subject Area
Subject Areas
- Biochemistry (10810)
- Bioengineering (8053)
- Bioinformatics (27345)
- Biophysics (13998)
- Cancer Biology (11137)
- Cell Biology (16077)
- Clinical Trials (138)
- Developmental Biology (8793)
- Ecology (13307)
- Epidemiology (2067)
- Evolutionary Biology (17374)
- Genetics (11692)
- Genomics (15938)
- Immunology (11042)
- Microbiology (26129)
- Molecular Biology (10669)
- Neuroscience (56654)
- Paleontology (420)
- Pathology (1737)
- Pharmacology and Toxicology (3009)
- Physiology (4555)
- Plant Biology (9647)
- Synthetic Biology (2694)
- Systems Biology (6985)
- Zoology (1511)